Heme Oxygenase-1 Induction and Organic Nitrate Therapy: Beneficial Effects on Endothelial Dysfunction, Nitrate Tolerance, and Vascular Oxidative Stress

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Daiber, Andreas ^a   Oelze, Matthias ^a   Wenzel, Philip ^a   Bollmann, Franziska ^a   Pautz, Andrea ^a   Kleinert, Hartmut ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; APIGENIN; BILIRUBIN; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GLYCERYL TRINITRATE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HEME OXYGENASE 1; HUR PROTEIN; ISOSORBIDE 5 NITRATE; ORGANIC NITRATE; PENTAERYTHRITYL TETRANITRATE; PIOGLITAZONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

BINDING SITE; BIOGENESIS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HO 1 SIGNALING PATHWAY; HUMAN; ISCHEMIC PRECONDITIONING; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84867500799     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/842632     Document Type: Review

References (95)

1. Munzel T., Daiber A., Mulsch A., Explaining the phenomenon of nitrate tolerance. Circulation Research 2005 97 7 618 628 2-s2.0-26244465889 10.1161/01.RES.0000184694.03262.6d (Pubitemid 41416330)
2. Munzel T., tmuenzel@uni-mainz.de Daiber A., Gori T., Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation 2011 123 19 2132 2144 10.1161/CIRCULATIONAHA.110.981407
3. Daiber A., Munzel T., Gori T., Organic nitrates and nitrate tolerancestate of the art and future developments. Advances in Pharmacology 2010 60 177 227 2-s2.0-78349243228 10.1016/B978-0-12-385061-4.00007-6
4. Daiber A., Oelze M., Wenzel P., Wickramanayake J. M. D., Schuhmacher S., Jansen T., Lackner K. J., Torzewski M., Munzel T., Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacological Reports 2009 61 1 33 48 2-s2.0-66949115572
5. Daiber A., Wenzel P., Oelze M., Munzel T., New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clinical Research in Cardiology 2008 97 1 12 20 2-s2.0-38149029311 10.1007/s00392-007-0588-7
6. Griendling K. K., FitzGerald G. A., Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 2003 108 17 2034 2040 2-s2.0-0242349764 10.1161/01.CIR.0000093661.90582.c4 (Pubitemid 37337574)
7. Daiber A., Münzel T., Oxidativer Stress, Redoxregulation und NO-BioverfügbarkeitExperimentelle und Klinische Aspekte 2006 Darmstadt, Germany Steinkopff Verlag Darmstadt
8. Schulz E., Tsilimingas N., Rinze R., Reiter B., Wendt M., Oelze M., Woelken-Weckmuller S., Walter U., Reichenspurner H., Meinertz T., Munzel T., Functional and biochemical analysis of endothelial (Dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 2002 105 10 1170 1175 2-s2.0-0037066021 10.1161/hc1002.105186 (Pubitemid 34225816)
9. Gori T., Al-Hesayen A., Jolliffe C., Parker J. D., Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers. American Journal of Cardiology 2003 91 11 1392 1394 2-s2.0-0037950145 10.1016/S0002-9149(03)00342-4 (Pubitemid 36593497)
10. Sekiya M., Sato M., Funada J., Ohtani T., Akutsu H., Watanabe K., Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. Journal of Cardiovascular Pharmacology 2005 46 1 63 67 2-s2.0-21444459240 10.1097/01.fjc.0000162771.00174.a8 (Pubitemid 40917780)
11. Thomas G. R., DiFabio J. M., Gori T., Parker J. D., Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans. Evidence of a free-radical-mediated mechanism. Journal of the American College of Cardiology 2007 49 12 1289 1295 2-s2.0-33947501974 10.1016/j.jacc.2006.10.074 (Pubitemid 46476841)
12. Munzel T., Sayegh H., Freeman B. A., Tarpey M. M., Harrison D. G., Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. Journal of Clinical Investigation 1995 95 1 187 194 2-s2.0-0028799761
13. Munzel T., Kurz S., Rajagopalan S., Thoenes M., Berrington W. R., Thompson J. A., Freeman B. A., Harrison D. G., Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. Journal of Clinical Investigation 1996 98 6 1465 1470 2-s2.0-0029780286 (Pubitemid 26322073)
14. Munzel T., Harrison D. G., Evidence for a role of oxygen derived free radicals and protein kinase C in nitrate tolerance. Journal of Molecular Medicine 1997 75 11-12 891 900 2-s2.0-0030830628 (Pubitemid 27511566)
15. Munzel T., Giaid A., Kurz S., Stewart D. J., Harrison D. G., Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proceedings of the National Academy of Sciences of the United States of America 1995 92 11 5244 5248 2-s2.0-0029063158 10.1073/pnas.92.11.5244
16. Warnholtz A., Mollnau H., Heitzer T., Kontush A., Möller-Bertram T., Lavall D., Giaid A., Beisiegel U., Marklund S. L., Walter U., Meinertz T., Munzel T., muenzel@uke.uni-hamburg.de Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. Journal of the American College of Cardiology 2002 40 7 1356 1363 10.1016/S0735-1097(02)02133-2
17. Hink U., Oelze M., Kolb P., Bachschmid M., Zou M. H., Daiber A., Mollnau H., August M., Baldus S., Tsilimingas N., Walter U., Ullrich V., Munzel T., Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. Journal of the American College of Cardiology 2003 42 10 1826 1834 2-s2.0-10744223291 10.1016/j.jacc.2003.07.009 (Pubitemid 37433665)
18. Daiber A., andreas.daiber@bioredox.com Oelze M., Coldewey M., Kaiser K., Huth C., Schildknecht S., Bachschmid M., Nazirisadeh Y., Ullrich V., Mülsch A., Münzel T., Tsilimingas N., Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochemical and Biophysical Research Communications 2005 338 4 1865 1874 10.1016/j.bbrc.2005.10.106 (Pubitemid 41643103)
19. Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., Ho K. K., Weiner H., Bachschmid M., Munzel T., Daiber A., Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity: implications for mitochondrial oxidative stress and nitrate tolerance. Journal of Biological Chemistry 2007 282 1 792 799 2-s2.0-33846969562 10.1074/jbc.M606477200 (Pubitemid 47076617)
20. Fan Q., Gao F., Zhang L., Christopher T. A., Lopez B. L., Ma X. L., Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia. Apoptosis 2005 10 6 1235 1242 2-s2.0-30944460125 10.1007/s10495-005-1455-5 (Pubitemid 43117672)
21. Abou-Mohamed G., Johnson J. A., Jin L., El-Remessy A. B., Do K., Kaesemeyer W. H., Caldwell R. B., Caldwell R. W., Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. Journal of Pharmacology and Experimental Therapeutics 2004 308 1 289 299 2-s2.0-0347758408 10.1124/jpet.103.056119 (Pubitemid 38090730)
22. Mihm M. J., Coyle C. M., Jing L., Bauer J. A., Vascular peroxynitrite formation during organic nitrate tolerance. Journal of Pharmacology and Experimental Therapeutics 1999 291 1 194 198 2-s2.0-0032842403 (Pubitemid 29451590)
23. Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., Ullrich V., Mülsch A., Schulz E., Keaney J. F. Jr., Stamler J. S., Munzel T., muenzel@uke.uni-hamburg.de Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. Journal of Clinical Investigation 2004 113 3 482 489 10.1172/JCI200419267 (Pubitemid 38544192)
24. Chen Z., Zhang J., Stamler J. S., Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proceedings of the National Academy of Sciences of the United States of America 2002 99 12 8306 8311 2-s2.0-0037062518 10.1073/pnas.122225199 (Pubitemid 34651048)
25. Needleman P., Hunter F. E. Jr., Effects of organic nitrates on mitochondrial respiration and swelling: possible correlations with the mechanism of pharmacologic action. Molecular Pharmacology 1966 2 2 134 143 2-s2.0-0013887461
26. Jakschik B., Needleman P., Sulfhydryl reactivity of organic nitrates: biochemical basis for inhibition of glyceraldehyde p dehydrogenase and monoamine oxidase. Biochemical and Biophysical Research Communications 1973 53 2 539 544 2-s2.0-0015828822
27. Daiber A., andreas.daiber@bioredox.com Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., Wendt M., Kleschyov A. L., Stalleicken D., Ullrich V., Mülsch A., Münzel T., Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Molecular Pharmacology 2004 66 6 1372 1382 10.1124/mol.104.002600 (Pubitemid 39564764)
28. Daiber A., Oelze M., Sulyok S., Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Molecular Pharmacology 2005 68 3 579 588 (Pubitemid 41206011)
29. Mollnau H., Wenzel P., Oelze M., Treiber N., Pautz A., Schulz E., Schuhmacher S., Reifenberg K., Stalleicken D., Scharffetter-Kochanek K., Kleinert H., Munzel T., Daiber A., Mitochondrial oxidative stress and nitrate tolerancecomparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice. BMC Cardiovascular Disorders 2006 6, article 44 2-s2.0-33751347144 10.1186/1471-2261-6-44 (Pubitemid 44803699)
30. Esplugues J. V., Rocha M., Nunez C., Bosca I., Ibiza S., Herance J. R., Ortega A., Serrador J. M., D'Ocon P., Victor V. M., Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circulation Research 2006 99 10 1067 1075 2-s2.0-33750930318 10.1161/01.RES.0000250430.62775.99 (Pubitemid 44729930)
31. Wenzel P., Oelze M., Coldewey M., Hortmann M., Seeling A., Hink U., Mollnau H., Stalleicken D., Weiner H., Lehmann J., Li H., Förstermann U., Münzel T., tmuenzel@uni-mainz.de Daiber A., Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 8 1729 1735 10.1161/ATVBAHA.107.143909 (Pubitemid 47207167)
32. Schuhmacher S., Wenzel P., Schulz E., Oelze M., Mang C., Kamuf J., Gori T., Jansen T., Knorr M., Karbach S., Hortmann M., Mäthner F., Bhatnagar A., Förstermann U., Li H., Münzel T., Daiber A., daiber@uni-mainz.de Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1. Hypertension 2010 55 4 897 904 10.1161/HYPERTENSIONAHA.109.149542
33. Alam J., Cook J. L., How many transcription factors does it take to turn on the heme oxygenase-1 gene? American Journal of Respiratory Cell and Molecular Biology 2007 36 2 166 174 2-s2.0-33846924300 10.1165/rcmb.2006-0340TR (Pubitemid 46233469)
34. Schuhmacher S., Oelze M., Bollmann F., Kleinert H., Otto C., Heeren T., Steven S., Hausding M., Knorr M., Pautz A., Reifenberg K., Schulz E., Gori T., Wenzel P., Münzel T., Daiber A., andreas.daiber@bioredox.com Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes 2011 60 10 2608 2616 10.2337/db10-1395
35. Oberle S., Abate A., Grosser N., Vreman H. J., Dennery P. A., Schneider H. T., Stalleicken D., Schröder H., Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate. Biochemical and Biophysical Research Communications 2002 290 5 1539 1544 10.1006/bbrc.2002.6379 (Pubitemid 34687433)
36. Oberle S., Schwartz P., Abate A., Schroder H., The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochemical and Biophysical Research Communications 1999 261 1 28 34 10.1006/bbrc.1999.0941 (Pubitemid 29371613)
37. Grosser N., Hemmerle A., Berndt G., Erdmann K., Hinkelmann U., Schurgerc S., Wijayanti N., Immenschuh S., Schröder H., The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radical Biology and Medicine 2004 37 12 2064 2071 2-s2.0-8544284074 10.1016/j.freeradbiomed.2004.09.009 (Pubitemid 39491325)
38. Gueler F., Park J. K., Rong S., Kirsch T., Lindschau C., Zheng W., Elger M., Fiebeler A., Fliser D., Luft F. C., Haller H., Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. American Journal of Pathology 2007 170 4 1192 1199 2-s2.0-34247869755 10.2353/ajpath.2007.060782 (Pubitemid 47339327)
39. Fontaine D., Otto A., Fontaine J., Berkenboom G., Prevention of nitrate tolerance by long-term treatment with statins. Cardiovascular Drugs and Therapy 2003 17 2 123 128 2-s2.0-0141651564 10.1023/A:1025383601304 (Pubitemid 37174685)
40. Inoue T., Takayanagi K., Hayashi T., Morooka S., Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia. International Journal of Cardiology 2003 90 2-3 181 188 2-s2.0-0041382453 10.1016/S0167-5273(02)00529-6 (Pubitemid 37087876)
41. Liuni A., Luca M. C., Di Stolfo G., Uxa A., Mariani J. A., Gori T., Parker J. D., Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans. Journal of the American College of Cardiology 2011 57 1 93 98 2-s2.0-78650572913 10.1016/j.jacc.2010.07.037
42. Jansen T., Hortmann M., Oelze M., Opitz B., Steven S., Schell R., Knorr M., Karbach S., Schuhmacher S., Wenzel P., Munzel T., Daiber A., Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. Journal of Molecular and Cellular Cardiology 2010 49 2 186 195 2-s2.0-77953704443 10.1016/j.yjmcc.2010.04.011
43. Knorr M., Hausding M., Kroller-Schuhmacher S., Steven S., Oelze M., Heeren T., Scholz A., Gori T., Wenzel P., Schulz E., Daiber A., andreas.daiber@bioredox.com Münzel T., tmuenzel@uni-mainz.de Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 10 2223 2231 10.1161/ATVBAHA.111.232058
44. Alp N. J., Mussa S., Khoo J., Cai S., Guzik T., Jefferson A., Goh N., Rockett K. A., Channon K. M., Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. Journal of Clinical Investigation 2003 112 5 725 735 2-s2.0-0141612000 10.1172/JCI200317786 (Pubitemid 38057713)
45. Antoniades C., Cunnington C., Antonopoulos A., Neville M., Margaritis M., Demosthenous M., Bendall J., Hale A., Cerrato R., Tousoulis D., Bakogiannis C., Marinou K., Toutouza M., Vlachopoulos C., Leeson P., Stefanadis C., Karpe F., Channon K. M., Keith.channon@cardiov.ox.ac.uk Induction of vascular GTP-cyclohydrolase i and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis. Circulation 2011 124 17 1860 1870 10.1161/CIRCULATIONAHA.111.029272
46. Xu J., Wu Y., Song P., Zhang M., Wang S., Zou M. H., Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 2007 116 8 944 953 2-s2.0-34548134851 10.1161/CIRCULATIONAHA.106.684795 (Pubitemid 47300919)
47. Abraham N. G., naderabraham@nymc.edu Kappas A., Pharmacological and clinical aspects of heme oxygenase. Pharmacological Reviews 2008 60 1 79 127 10.1124/pr.107.07104 (Pubitemid 351439218)
48. Oppermann M., Balz V., Adams V., Thao-Vi Dao V., Bas M., Suvorava T., Kojda G., Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo. Journal of Cellular and Molecular Medicine 2009 13 7 1271 1278 2-s2.0-68149109919 10.1111/j.1582-4934.2008.00627.x
49. Jones A. W., Durante W., Korthuis R. J., Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. Journal of Pharmacology and Experimental Therapeutics 2010 335 1 85 91 2-s2.0-77957234852 10.1124/jpet.110.169755
50. Gori T., Daiber A., Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate. American Journal of Cardiovascular Drugs 2009 9 1 7 15 2-s2.0-59349090968 10.2165/00129784- 200909010-00002
51. Kleschyov A. L., Oelze M., Daiber A., Huang Y., Mollnau H., Schulz E., Sydow K., Fichtlscherer B., Mulsch A., Munzel T., Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circulation Research 2003 93 9 e104 112 2-s2.0-10044220171
52. Thum T., Fraccarollo D., Thum S., Schultheiss M., Daiber A., Wenzel P., Munzel T., Ertl G., Bauersachs J., Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 748 754 2-s2.0-34247231687 10.1161/01.ATV.0000258787.18982.73 (Pubitemid 46606702)
53. DiFabio J. M., Thomas G. R., Zucco L., Kuliszewski M. A., Bennett B. M., Kutryk M. J., Parker J. D., Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. Journal of Pharmacology and Experimental Therapeutics 2006 318 1 117 123 2-s2.0-33745258234 10.1124/jpet.106.102129
54. Lin H. H., Chen Y. H., Chang P. F., Lee Y. T., Yet S. F., Chau L. Y., Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. Journal of Molecular and Cellular Cardiology 2008 45 1 44 55 2-s2.0-45549097135 10.1016/j.yjmcc.2008.04.011
55. Thum T., Fraccarollo D., Schultheiss M., Froese S., Galuppo P., Widder J. D., Tsikas D., Ertl G., Bauersachs J., Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 3 666 674 2-s2.0-33847346061 10.2337/db06-0699 (Pubitemid 46348461)
56. Gori T., Burstein J. M., Ahmed S., Miner S. E. S., Al-Hesayen A., Kelly S., Parker J. D., Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 2001 104 10 1119 1123 2-s2.0-0035806914 (Pubitemid 32830394)
57. Ikejima H., Imanishi T., Tsujioka H., Kuroi A., Muragaki Y., Mochizuki S., Goto M., Yoshida K., Akasaka T., Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor. Circulation Journal 2008 72 6 998 1002 2-s2.0-45849114694 10.1253/circj.72.998 (Pubitemid 351879924)
58. Schmidt K., Rehn M., Stessel H., Wolkart G., Mayer B., Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerin. Free Radical Biology and Medicine 2010 48 1 145 152 2-s2.0-74149093121 10.1016/j.freeradbiomed.2009.10.038
59. Gori T., Dragoni S., Di Stolfo G., Sicuro S., Liuni A., Luca M. C., Thomas G., Oelze M., Daiber A., Parker J. D., Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. American Journal of Physiology 2010 298 2 H340 H345 2-s2.0-74949119593 10.1152/ajpheart.01324.2008
60. Gori T., Lisi M., Forconi S., Ischemia and reperfusion: the endothelial perspective. A radical view. Clinical Hemorheology and Microcirculation 2006 35 1-2 31 34 2-s2.0-33746461814 (Pubitemid 44126475)
61. Gori T., Parker J. D., Nitrate-induced toxicity and preconditioning. A rationale for reconsidering the use of these drugs. Journal of the American College of Cardiology 2008 52 4 251 254 2-s2.0-46849092968 10.1016/j.jacc.2008. 04.019 (Pubitemid 351957846)
62. Dragoni S., Gori T., Lisi M., Di Stolfo G., Pautz A., Kleinert H., Parker J. D., Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 9 1955 1959 2-s2.0-34548160261 10.1161/ATVBAHA.107.149278 (Pubitemid 47312304)
63. Das D. K., Maulik N., Cardiac genomic response following preconditioning stimulus. Cardiovascular Research 2006 70 2 254 263 2-s2.0-33748252653 10.1016/j.cardiores.2006.02.023 (Pubitemid 44316806)
64. Jancso G., jancsogabor@hotmail.com Cserepes B., Gasz B., Benkó L., Borsiczky B., Ferenc A., Kürthy M., Rácz B., Lantos J., Gal J., Arató E., Sínayc L., Wéber G., Róth E., Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Annals of the New York Academy of Sciences 2007 1095 251 261 10.1196/annals.1397.029 (Pubitemid 47092457)
65. Vitek L., Schwertner H. A., The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Advances in Clinical Chemistry 2007 43 1 57 2-s2.0-33845613215 10.1016/S0065-2423(06)43001-8 (Pubitemid 44960959)
66. Converso D. P., Taille C., Carreras M. C., Jaitovich A., Poderoso J. J., Boczkowski J., HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. The FASEB Journal 2006 20 8 1236 1238 2-s2.0-33746026643 10.1096/fj.05-4204fje (Pubitemid 44943883)
67. Suliman H. B., Carraway M. S., Ali A. S., Reynolds C. M., Welty-Wolf K. E., Piantadosi C. A., The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. Journal of Clinical Investigation 2007 117 12 3730 3741 2-s2.0-36849079020 10.1172/JCI32967 (Pubitemid 350224084)
68. Bindu S., Pal C., Dey S., Goyal M., Alam A., Iqbal M. S., Dutta S., Sarkar S., Kumar R., Maity P., Bandyopadhyay U., ubandyo1964@yahoo.com Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. Journal of Biological Chemistry 2011 286 45 39387 39402 10.1074/jbc.M111.279893
69. Wenzel P., Mollnau H., Oelze M., Schulz E., Wickramanayake J. M. D., Muller J., Schuhmacher S., Hortmann M., Baldus S., Gori T., Brandes R. P., Munzel T., Daiber A., First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxidants and Redox Signaling 2008 10 8 1435 1447 2-s2.0-44049088536 10.1089/ars.2007.1969
70. Daiber A., Munzel T., Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1). Methods in Molecular Biology 2010 594 311 326 2-s2.0-77950350705 10.1007/978-1-60761-411-122
71. Jurt U., Gori T., Ravandi A., Babaei S., Zeman P., Parker J. D., Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. Journal of the American College of Cardiology 2001 38 3 854 859 2-s2.0-0034846916 10.1016/S0735-1097(01)01414-0 (Pubitemid 32835764)
72. Pfeilschifter J., Beck K. F., Cadenas E., Lamas S., Nitric oxide and gene expression. Nitric Oxide, Cell Signaling, and Gene Expression 2005 Boca Raton, Fla, USA Taylor & Francis 327 348
73. Thum T., ThumT@klinik.uni-wuerzburg.de Bauersachs J., Microarray-based gene expression profiling to elucidate cellular responses to nitric oxide-a review from an analytical and biomedical point of view. Journal of Chromatography B 2007 851 1-2 3 11 10.1016/j.jchromb.2006.07.023 (Pubitemid 46720131)
74. Bogdan C., Nitric oxide and the regulation of gene expression. Trends in Cell Biology 2001 11 2 66 75 2-s2.0-0035253023 10.1016/S0962-8924(00)01900-0 (Pubitemid 32144753)
75. Pilz R. B., Casteel D. E., Regulation of gene expression by cyclic GMP. Circulation Research 2003 93 11 1034 1046 2-s2.0-0344011964 10.1161/01.RES. 0000103311.52853.48 (Pubitemid 37485034)
76. Buckley B. J., Marshall Z. M., Whorton A. R., Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochemical and Biophysical Research Communications 2003 307 4 973 979 2-s2.0-0037767747 10.1016/S0006-291X(03)01308-1 (Pubitemid 36871668)
77. Kuwano Y., Rabinovic A., Srikantan S., Gorospe M., Demple B., Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation. Molecular and Cellular Biology 2009 29 10 2622 2635 2-s2.0-66349115397 10.1128/MCB.01495-08
78. Tassorelli C., Joseph S. A., NADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administration. Brain Research 1995 695 1 37 44 2-s2.0-0028784550 10.1016/0006-8993(95)00732-6
79. Tassorelli C., Greco R., Armentero M. T., Blandini F., Sandrini G., Nappi G., A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. International Review of Neurobiology 2007 82 373 382 2-s2.0-34547367445 10.1016/S0074-7742(07)82020-4
80. Greco R., Amantea D., Blandini F., Nappi G., Bagetta G., Corasaniti M. T., Tassorelli C., Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression. International Review of Neurobiology 2007 82 423 435 2-s2.0-34547277497 10.1016/S0074-7742(07)82024-1
81. Suwattanasophon C., Phansuwan-Pujito P., Srikiatkhachorn A., 5-HT1B/1D serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway. Cephalalgia 2003 23 8 825 832 2-s2.0-0141924638 10.1046/j.1468-2982.2003.00583.x (Pubitemid 37255425)
82. Prevotat L., Filomenko R., Solary E., Jeannin J. F., Bettaieb A., Nitric oxide-induced down-regulation of β -catenin in colon cancer cells by a proteasome-independent specific pathway. Gastroenterology 2006 131 4 1142 1152 2-s2.0-33749465610 10.1053/j.gastro.2006.07.017 (Pubitemid 44515097)
83. Szocs K., Lassegue B., Wenzel P., Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. Journal of Molecular and Cellular Cardiology 2007 42 6 1111 1118 (Pubitemid 46829198)
84. Wang E. Q., Lee W. I., Brazeau D., Fung H. L., cDNA microarray analysis of vascular gene expression after nitric oxide donor infusions in rats: implications for nitrate tolerance mechanisms. AAPS PharmSci 2002 4 2, article E10 2-s2.0-0036451141
85. Pautz A., Rauschkolb P., Schmidt N., Art J., Oelze M., Wenzel P., Förstermann U., Daiber A., Kleinert H., Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects. Physiological Genomics 2009 38 2 176 185 2-s2.0-67650251652 10.1152/physiolgenomics.00035.2009
86. Dhakshinamoorthy S., Porter A. G., Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. Journal of Biological Chemistry 2004 279 19 20096 20107 2-s2.0-2442535969 10.1074/jbc.M312492200 (Pubitemid 38623454)
87. Liu X. M., Peyton K. J., Ensenat D., Wang H., Hannink M., Alam J., Durante W., Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovascular Research 2007 75 2 381 389 2-s2.0-34250706879 10.1016/j.cardiores.2007.03.004 (Pubitemid 46961918)
88. Hartsfield C. L., Alam J., Cook J. L., Choi A. M., Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. American Journal of Physiology 1997 273 5, part 1 L980 L988 2-s2.0-0030669601
89. Bouton C., Demple B., Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-independent stabilization of the mRNA and evidence for direct action of nitric oxide. Journal of Biological Chemistry 2000 275 42 32688 32693 2-s2.0-0034693134
90. Leautaud V., Demple B., Regulation of heme oxygenase-1 mRNA deadenylation and turnover in NIH3T3 cells by nitrosative or alkylation stress. BMC Molecular Biology 2007 8, article 116 2-s2.0-39549123399 10.1186/1471-2199-8-116 (Pubitemid 351280039)
91. Hinkelmann U., Grosser N., Erdmann K., Schroder H., Immenschuh S., Immenschuh.Stephan@mh-hannover.de Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. European Journal of Pharmaceutical Sciences 2010 41 1 118 124 10.1016/j.ejps.2010.05.021
92. Beckman J. D., Chen C., Nguyen J., Thayanithy V., Subramanian S., Steer C. J., Vercellotti G. M., verce001@umn.edu Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. Journal of Biological Chemistry 2011 286 5 3194 3202 10.1074/jbc.M110.148726
93. Misquitta C. M., Iyer V. R., Werstiuk E. S., Grover A. K., The role of 3′ -untranslated region (3′ -UTR) mediated mRNA stability in cardiovascular pathophysiology. Molecular and Cellular Biochemistry 2001 224 1-2 53 67 2-s2.0-0034740869 10.1023/A:1011982932645 (Pubitemid 32962652)
94. Khabar K. S., The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. Journal of Interferon and Cytokine Research 2005 25 1 1 10 2-s2.0-12144251356 (Pubitemid 40105586)
95. Hacker A., Muller S., Meyer W., Kojda G., The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. British Journal of Pharmacology 2001 132 8 1707 1714 2-s2.0-0035040966 (Pubitemid 32397962)